Transpharmation acquires OrganoTherapeutics

Transpharmation, a preclinical contract research firm in neuroscience, pain and metabolic disease, acquired OrganoTherapeutics, which provides patient-derived organoid technologies for neurodegenerative and CNS research, as a step toward animal-free models.